Global Cell therapy Technologies Market Size study, by Product (Consumables, Equipment, Systems & Software), Process (Cell Processing, Cell prevention, Distribution, and Handling), Cell Type (Human Cells, Animal Cells), End User (Life Science Research Companies, Research Institutes) and Regional Forecasts 2019-2026
Global Cell therapy Technologies is valued approximately USD 10.2 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 14.4% over the forecast period 2019-2026. Cell therapy refers to the biological activities carried out by cells that would lead to a desired effect either in vivo or in vitro. In cell therapy, cell suspensions enter into an organ or tissue or the blood stream with the possibility that these cells would be able to heal any injury. The main aim of cell therapy is to target various diseases at the cellular level by restoring a certain cell population as carriers of therapeutic cargo. cell therapy can be used for the treatment of a variety of diseases including treatment of cancers, urinary problems, autoimmune disease, and infectious disease, repairing spinal cord injuries, rebuilding damaged cartilage in joints, improving the immune system, and treatment of neurological disorders.Rising funding from government as well as private organizations to support cell therapy clinical trials has increased the demand of this market. Additionally, introduction of effective guidelines for cell therapy manufacturing, and proven effectiveness of products driven the growth of Cell Therapy Market over the forecast period of 2019-2026.
The regional analysis of global Cell therapy Technologies is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. The North America is the leading region across the world. The implementation of stringent regulations and increasing R&D activities in the pharmaceutical and biotechnology industries are the key drivers for market growth in this region.
Major market player included in this report are:
Thermo Fisher Scientific, Inc.
Merck KGaA
Terumo Bct, Inc.
Lonza Group
Ge Healhcare
Sartorius
Becton, Dickinson and Company
Beckman Coulter, Inc.
Miltenyi Biotec GmbH
Stemcell Technologies
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Consumables
Equipment
Systems & Software
By Process:
Cell Processing
Cell prevention
Distribution, and Handling
By Cell Type:
Human Cells
Animal Cells
By End User:
Life Science Research Companies
Research Institutes
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026
Target Audience of the Global Cell therapy Technologies in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
The regional analysis of global Cell therapy Technologies is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. The North America is the leading region across the world. The implementation of stringent regulations and increasing R&D activities in the pharmaceutical and biotechnology industries are the key drivers for market growth in this region.
Major market player included in this report are:
Thermo Fisher Scientific, Inc.
Merck KGaA
Terumo Bct, Inc.
Lonza Group
Ge Healhcare
Sartorius
Becton, Dickinson and Company
Beckman Coulter, Inc.
Miltenyi Biotec GmbH
Stemcell Technologies
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Consumables
Equipment
Systems & Software
By Process:
Cell Processing
Cell prevention
Distribution, and Handling
By Cell Type:
Human Cells
Animal Cells
By End User:
Life Science Research Companies
Research Institutes
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026
Target Audience of the Global Cell therapy Technologies in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1.EXECUTIVE SUMMARY
1.1.Market Snapshot
1.2.Key Trends
1.3.Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
1.3.1.Cell Therapy Technologies Market, by Implementation Type, 2016-2026 (USD Billion)
1.3.2.Cell Therapy Technologies Market, by Measurement Technology, 2016-2026 (USD Billion)
1.3.3.Cell Therapy Technologies Market, by Cell Type, 2016-2026 (USD Billion)
1.3.4.Cell Therapy Technologies Market, by End User, 2016-2026 (USD Billion)
1.3.5.Cell Therapy Technologies Market, by Region, 2016-2026 (USD Billion)
1.4.Estimation Methodology
1.5.Research Assumption
CHAPTER 2.GLOBAL CELL THERAPY TECHNOLOGIES MARKET DEFINITION AND SCOPE
2.1.Objective of the Study
2.2.Market Definition & Scope
2.2.1.Industry Evolution
2.2.2.Scope of the Study
2.3.Years Considered for the Study
2.4.Currency Conversion Rates
CHAPTER 3.GLOBAL CELL THERAPY TECHNOLOGIES MARKET DYNAMICS
3.1.See Saw Analysis
3.1.1.Market Drivers
3.1.2.Market Challenges
3.1.3.Market Opportunities
CHAPTER 4.GLOBAL CELL THERAPY TECHNOLOGIES MARKET INDUSTRY ANALYSIS
4.1.Porter’s 5 Force Model
4.1.1.Bargaining Power of Buyers
4.1.2.Bargaining Power of Suppliers
4.1.3.Threat of New Entrants
4.1.4.Threat of Substitutes
4.1.5.Competitive Rivalry
4.1.6.Futuristic Approach to Porter’s 5 Force Model
4.2.PEST Analysis
4.2.1.Political Scenario
4.2.2.Economic Scenario
4.2.3.Social Scenario
4.2.4.Technological Scenario
4.3.Key Buying Criteria (On Demand)
4.4.Regulatory Framework (On Demand)
4.5.Investment Vs Adoption Scenario (On Demand)
4.6.Analyst Recommendation & Conclusion
CHAPTER 5.GLOBAL CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT
5.1.Market Snapshot
5.2.Market Performance - Potential Model
5.3.Cell Therapy Technologies Market, Sub Segment Analysis
5.3.1. Consumables
5.3.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.1.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.2. Equipment
5.3.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.2.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.2.3.Market sub segment
5.3.2.3.1.Cell Processing Equipment
5.3.2.3.2.Single-Use Equipment
5.3.2.3.3.Other Equipment
5.3.3. Systems & Software
5.3.3.1.Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.3.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
CHAPTER 6.GLOBAL CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS
6.1.Market Snapshot
6.2.Market Performance - Potential Model
6.3.Cell Therapy Technologies Market, Sub Segment Analysis
6.3.1. Cell Processing
6.3.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.1.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.2. Cell Preservation, Distribution, and Handling
6.3.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.2.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.3.Process Monitoring and Quality Control
6.3.3.1.Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.3.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
CHAPTER 7.GLOBAL CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE
7.1.Market Snapshot
7.2.Market Performance - Potential Model
7.3.Cell Therapy Technologies Market, Sub Segment Analysis
7.3.1. Human Cells
7.3.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.1.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.1.3.Market Sub Segment
7.3.1.3.1.Stem Cells
7.3.1.3.2.Differentiated Cells
7.3.2. Animal Cells
7.3.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
CHAPTER 8.GLOBAL CELL THERAPY TECHNOLOGIES MARKET, BY END-USER
8.1.Market Snapshot
8.2.Market Performance - Potential Model
8.3.Cell Therapy Technologies Market, Sub Segment Analysis
8.3.1. Life Science Research Companies
8.3.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
8.3.1.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.2. Research Institutes
8.3.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
8.3.2.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
CHAPTER 9.GLOBAL CELL THERAPY TECHNOLOGIES MARKET, BY REGIONAL ANALYSIS
9.1.Cell Therapy Technologies Market, Regional Market Snapshot (2016-2026)
9.2.North America Cell Therapy Technologies Market Snapshot
9.2.1.U.S.
9.2.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
9.2.1.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.2.1.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.2.1.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.2.1.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.2.2.Canada
9.2.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
9.2.2.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.2.2.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.2.2.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.2.2.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.Europe Cell Therapy Technologies Market Snapshot
9.3.1.U.K.
9.3.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
9.3.1.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.1.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.1.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.1.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.1.6.
9.3.2.Rest of Europe
9.3.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
9.3.2.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.2.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.2.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.2.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.Asia Cell Therapy Technologies Market Snapshot
9.4.1.China
9.4.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
9.4.1.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.1.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.1.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.1.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.2.India
9.4.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
9.4.2.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.2.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.2.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.2.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.3.Japan
9.4.3.1.Market estimates & forecasts, 2016-2026 (USD Billion)
9.4.3.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.3.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.3.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.3.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.4.Rest of Asia Pacific
9.4.4.1.Market estimates & forecasts, 2016-2026 (USD Billion)
9.4.4.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.4.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.4.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.4.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5.Latin America Cell Therapy Technologies Market Snapshot
9.5.1.Brazil
9.5.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
9.5.1.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5.1.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5.1.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5.1.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5.2.Mexico
9.5.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
9.5.2.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5.2.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5.2.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5.2.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.6.Rest of The World
9.6.1.Middle East and Africa
9.6.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
9.6.1.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.6.1.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.6.1.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.6.1.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
CHAPTER 10.COMPETITIVE INTELLIGENCE
10.1.Company Market Share (Subject to Data Availability)
10.2.Top Market Strategies
10.3.Company Profiles
10.3.1. Thermo Fisher Scientific, Inc.
10.3.1.1.Overview
10.3.1.2.Financial (Subject to Data Availability)
10.3.1.3.Product Summary
10.3.1.4.Recent Developments
10.3.2. Merck KGaA
10.3.3.Terumo Bct, Inc.
10.3.4.Lonza Group
10.3.5.Ge Healhcare
10.3.6.Sartorius
10.3.7.Becton, Dickinson and Company
10.3.8.Beckman Coulter, Inc.
10.3.9.Miltenyi Biotec GmbH
10.3.10.Stemcell Technologies
CHAPTER 11.RESEARCH PROCESS
11.1.Research Process
11.1.1.Data Mining
11.1.2.Analysis
11.1.3.Market Estimation
11.1.4.Validation
11.1.5.Publishing
11.1.6.Research Assumption
1.1.Market Snapshot
1.2.Key Trends
1.3.Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
1.3.1.Cell Therapy Technologies Market, by Implementation Type, 2016-2026 (USD Billion)
1.3.2.Cell Therapy Technologies Market, by Measurement Technology, 2016-2026 (USD Billion)
1.3.3.Cell Therapy Technologies Market, by Cell Type, 2016-2026 (USD Billion)
1.3.4.Cell Therapy Technologies Market, by End User, 2016-2026 (USD Billion)
1.3.5.Cell Therapy Technologies Market, by Region, 2016-2026 (USD Billion)
1.4.Estimation Methodology
1.5.Research Assumption
CHAPTER 2.GLOBAL CELL THERAPY TECHNOLOGIES MARKET DEFINITION AND SCOPE
2.1.Objective of the Study
2.2.Market Definition & Scope
2.2.1.Industry Evolution
2.2.2.Scope of the Study
2.3.Years Considered for the Study
2.4.Currency Conversion Rates
CHAPTER 3.GLOBAL CELL THERAPY TECHNOLOGIES MARKET DYNAMICS
3.1.See Saw Analysis
3.1.1.Market Drivers
3.1.2.Market Challenges
3.1.3.Market Opportunities
CHAPTER 4.GLOBAL CELL THERAPY TECHNOLOGIES MARKET INDUSTRY ANALYSIS
4.1.Porter’s 5 Force Model
4.1.1.Bargaining Power of Buyers
4.1.2.Bargaining Power of Suppliers
4.1.3.Threat of New Entrants
4.1.4.Threat of Substitutes
4.1.5.Competitive Rivalry
4.1.6.Futuristic Approach to Porter’s 5 Force Model
4.2.PEST Analysis
4.2.1.Political Scenario
4.2.2.Economic Scenario
4.2.3.Social Scenario
4.2.4.Technological Scenario
4.3.Key Buying Criteria (On Demand)
4.4.Regulatory Framework (On Demand)
4.5.Investment Vs Adoption Scenario (On Demand)
4.6.Analyst Recommendation & Conclusion
CHAPTER 5.GLOBAL CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT
5.1.Market Snapshot
5.2.Market Performance - Potential Model
5.3.Cell Therapy Technologies Market, Sub Segment Analysis
5.3.1. Consumables
5.3.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.1.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.2. Equipment
5.3.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.2.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.2.3.Market sub segment
5.3.2.3.1.Cell Processing Equipment
5.3.2.3.2.Single-Use Equipment
5.3.2.3.3.Other Equipment
5.3.3. Systems & Software
5.3.3.1.Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.3.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
CHAPTER 6.GLOBAL CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS
6.1.Market Snapshot
6.2.Market Performance - Potential Model
6.3.Cell Therapy Technologies Market, Sub Segment Analysis
6.3.1. Cell Processing
6.3.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.1.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.2. Cell Preservation, Distribution, and Handling
6.3.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.2.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.3.Process Monitoring and Quality Control
6.3.3.1.Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.3.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
CHAPTER 7.GLOBAL CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE
7.1.Market Snapshot
7.2.Market Performance - Potential Model
7.3.Cell Therapy Technologies Market, Sub Segment Analysis
7.3.1. Human Cells
7.3.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.1.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.1.3.Market Sub Segment
7.3.1.3.1.Stem Cells
7.3.1.3.2.Differentiated Cells
7.3.2. Animal Cells
7.3.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
CHAPTER 8.GLOBAL CELL THERAPY TECHNOLOGIES MARKET, BY END-USER
8.1.Market Snapshot
8.2.Market Performance - Potential Model
8.3.Cell Therapy Technologies Market, Sub Segment Analysis
8.3.1. Life Science Research Companies
8.3.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
8.3.1.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.2. Research Institutes
8.3.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
8.3.2.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
CHAPTER 9.GLOBAL CELL THERAPY TECHNOLOGIES MARKET, BY REGIONAL ANALYSIS
9.1.Cell Therapy Technologies Market, Regional Market Snapshot (2016-2026)
9.2.North America Cell Therapy Technologies Market Snapshot
9.2.1.U.S.
9.2.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
9.2.1.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.2.1.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.2.1.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.2.1.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.2.2.Canada
9.2.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
9.2.2.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.2.2.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.2.2.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.2.2.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.Europe Cell Therapy Technologies Market Snapshot
9.3.1.U.K.
9.3.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
9.3.1.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.1.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.1.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.1.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.1.6.
9.3.2.Rest of Europe
9.3.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
9.3.2.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.2.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.2.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.3.2.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.Asia Cell Therapy Technologies Market Snapshot
9.4.1.China
9.4.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
9.4.1.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.1.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.1.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.1.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.2.India
9.4.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
9.4.2.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.2.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.2.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.2.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.3.Japan
9.4.3.1.Market estimates & forecasts, 2016-2026 (USD Billion)
9.4.3.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.3.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.3.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.3.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.4.Rest of Asia Pacific
9.4.4.1.Market estimates & forecasts, 2016-2026 (USD Billion)
9.4.4.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.4.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.4.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.4.4.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5.Latin America Cell Therapy Technologies Market Snapshot
9.5.1.Brazil
9.5.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
9.5.1.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5.1.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5.1.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5.1.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5.2.Mexico
9.5.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
9.5.2.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5.2.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5.2.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.5.2.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.6.Rest of The World
9.6.1.Middle East and Africa
9.6.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
9.6.1.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.6.1.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.6.1.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
9.6.1.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
CHAPTER 10.COMPETITIVE INTELLIGENCE
10.1.Company Market Share (Subject to Data Availability)
10.2.Top Market Strategies
10.3.Company Profiles
10.3.1. Thermo Fisher Scientific, Inc.
10.3.1.1.Overview
10.3.1.2.Financial (Subject to Data Availability)
10.3.1.3.Product Summary
10.3.1.4.Recent Developments
10.3.2. Merck KGaA
10.3.3.Terumo Bct, Inc.
10.3.4.Lonza Group
10.3.5.Ge Healhcare
10.3.6.Sartorius
10.3.7.Becton, Dickinson and Company
10.3.8.Beckman Coulter, Inc.
10.3.9.Miltenyi Biotec GmbH
10.3.10.Stemcell Technologies
CHAPTER 11.RESEARCH PROCESS
11.1.Research Process
11.1.1.Data Mining
11.1.2.Analysis
11.1.3.Market Estimation
11.1.4.Validation
11.1.5.Publishing
11.1.6.Research Assumption
